Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7302
    +0.0004 (+0.06%)
     
  • CRUDE OIL

    82.80
    -0.01 (-0.01%)
     
  • Bitcoin CAD

    88,225.08
    -3,117.32 (-3.41%)
     
  • CMC Crypto 200

    1,389.23
    -34.87 (-2.45%)
     
  • GOLD FUTURES

    2,320.50
    -17.90 (-0.77%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,458.25
    -206.25 (-1.17%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,818.11
    -641.97 (-1.67%)
     
  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Today’s Research Reports on Trending Tickers: Cigna Corporation and Finisar Corporation

NEW YORK, NY / ACCESSWIRE / March 9, 2018 / Stock markets closed higher Thursday as President Donald Trump imposed tariffs on imported steel and aluminum that excluded Canada and Mexico. The Dow Jones Industrial Average gained 0.38 percent to close at 24,895.21, while the S&P 500 Index increased 0.45 percent to close at 2,738.97. The Nasdaq Composite Index rose 0.42 percent to close at 7,427.95.

"The tariffs are driving volatility in the short term, but it seems like it is more about politics than a fundamental policy change, given the reports that Mexico and Canada could be exempt. We think the likelihood of a full trade war is low, and that any market dips are a buying opportunity," said Abe Sheikh, co-chief investment officer of Cougar Global, according to MarketWatch.

RDI Initiates Coverage on:

Cigna Corporation
https://rdinvesting.com/news/?ticker=CI

ADVERTISEMENT

Finisar Corporation
https://rdinvesting.com/news/?ticker=FNSR

Cigna's stock fell 11.45% Thursday, to close the day at $172.00. The stock recorded a trading volume of 17,356,969 shares, which was above its three months average volume of 1,379,485 shares. In the last year, Cigna's shares have traded in a range of 143.85 - 227.13. The share price has gained 19.57% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $202.54 is greater than its 200-day moving average of $197.24. Shares of Cigna Corporation are trading at a Price to Earnings ratio of 19.61. Shares of Cigna have fallen roughly 9.12 percent in the past month and are down 15.31 percent year-to-date.

Access RDI’s Cigna Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CI

On Thursday, shares of Finisar recorded a trading volume of 16,069,790 shares, which was above the three months average volume of 4,841,941 shares. The stock ended the day 0.88% lower at 20.22. The share price has gained 21.51% from its 52-week low with a 52-week trading range of 16.64 - 35.25. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $18.54 is below its 200-day moving average of $20.67. Shares of Finisar are trading at a Price to Earnings ratio of 11.58. Shares of Finisar have gained roughly 15.21 percent in the past month and are down 0.64 percent year-to-date.

Access RDI’s Finisar Corporation Research Report at:
https://rdinvesting.com/news/?ticker=FNSR

Our Actionable Research on Cigna Corporation (NYSE:CI) and Finisar Corporation (NASDAQ:FNSR) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com